CN111670985A - 一种含水溶性***二酚保健茶的制备方法 - Google Patents
一种含水溶性***二酚保健茶的制备方法 Download PDFInfo
- Publication number
- CN111670985A CN111670985A CN202010623392.2A CN202010623392A CN111670985A CN 111670985 A CN111670985 A CN 111670985A CN 202010623392 A CN202010623392 A CN 202010623392A CN 111670985 A CN111670985 A CN 111670985A
- Authority
- CN
- China
- Prior art keywords
- water
- cannabidiol
- soluble
- health tea
- soluble cannabidiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title claims abstract description 70
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title claims abstract description 70
- 229950011318 cannabidiol Drugs 0.000 title claims abstract description 70
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title claims abstract description 70
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title claims abstract description 62
- 241001122767 Theaceae Species 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 238000000605 extraction Methods 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 18
- 238000011049 filling Methods 0.000 claims description 15
- 229920002774 Maltodextrin Polymers 0.000 claims description 13
- 239000005913 Maltodextrin Substances 0.000 claims description 13
- 229940035034 maltodextrin Drugs 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 230000005484 gravity Effects 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000001728 nano-filtration Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims 2
- 230000003179 granulation Effects 0.000 claims 2
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000003796 beauty Effects 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 description 10
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 10
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 10
- 235000009120 camo Nutrition 0.000 description 10
- 235000005607 chanvre indien Nutrition 0.000 description 10
- 239000011487 hemp Substances 0.000 description 10
- 241000218236 Cannabis Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 229960004242 dronabinol Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 241000218235 Cannabaceae Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 201000007547 Dravet syndrome Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000006792 Lennox-Gastaut syndrome Diseases 0.000 description 1
- 208000036572 Myoclonic epilepsy Diseases 0.000 description 1
- 206010073677 Severe myoclonic epilepsy of infancy Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Tea And Coffee (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于保健品技术领域,涉及一种含水溶性***二酚保健茶的制备方法。本发明是针对国内市场和国际市场的发展前景,致力于开发一种含水溶性***二酚保健茶的制备方法。通过包合法制备水溶性***二酚,提高CBD水溶性活性,配合组方中的中药材,发挥综合协同效应。本发明优点:1、把不溶于水的***二酚在未改变分子结构的前提下,通过包合法将高纯度的CBD包埋起来,极大的提高了CBD的水溶性、稳定性及生物利用度,充分发挥其功效,拓宽了CBD的应用领域。2、原料的提取能够充分的将原料成分溶出,更好的发挥其功效。本产品风味独特,保健功效明显,具有清热解毒、抗炎、抗氧化、调节免疫等功效,是一款集美容、养生、休闲于一体的保健茶。
Description
技术领域:
本发明属于保健品技术领域,涉及一种含水溶性***二酚保健茶的制备方法。
背景技术:
我国将工业***称为汉麻(hemp),是***科(Cannabinaceae)***属(Cannabis)一年生草本植物。工业***是指四氢***酚含量低于0.3%的***,获准合法种植的工业***,均是低含毒量的品种,这些工业***(THC<0.3%)被认为不具备毒品利用价值,但依旧全身是宝,其应用至少包括纺织、造纸、食品、医药、卫生、日化、皮革、汽车、建筑、装饰、包装等领域,是经典的生产原料。
工业***中量较为丰富的***二酚(CBD)是汉麻中一类重要的非精神活性物质,不仅可拮抗THC的致幻作用,而且具有抗氧化、抗肿瘤、抗炎、抗焦虑、抗痉挛、抗耐药性癫痫等多种生理活性,现已被FDA批准用于Lennox-Gastaut综合征和Dravet综合征的临床治疗。
随着各国工业***合法化的推进,工业***成为当下全球投资最为火热的领域之一。保健茶是在长期预防疾病与保健的过程中,以中草药为原料,以传统中医养生理论为指导,总结出的一种适合当地气候和地理环境特点的,具有清热解毒、生津止渴、祛火除湿等功效的代用茶,其代用茶既无剂量限制,也无需医生指导,是药食同源不治已病治未病的保健代用茶。开发一款含CBD的保健茶不仅能满足年轻人追求潮流和个性,还具有清热解毒、改善睡眠、抗氧化、抗炎、调节免疫力等诸多保健功能,市场前景十分广阔。
发明内容:
本发明是针对国内市场和国际市场的发展前景,致力于开发一种含水溶性***二酚保健茶的制备方法。通过麦芽糊精的包合法制备水溶性***二酚,提高CBD水溶性活性,配合组方中的中药材,发挥综合协同效应。本发明制备的保健茶为袋装茶,产品具有清热解毒、抗衰老、抗炎、调节机体免疫力等多重保健功效。
为实现上述目的,本发明采用的技术方案是:
一种含水溶性***二酚保健茶的制备方法,其特征在于,以重量份计,包括以下组分:
本发明提供了一种含水溶性***二酚保健茶的制备方法,包括以下步骤:
(1)原料准备:将所用原料用清水洗净,粉碎,放入提取罐中进行超声波逆流提取,料液比为1∶12,正向进料、反向进水,物料与水的流动为逆向连续动态流动。功率在200~600W,萃取时间60~120min,萃取温度为60~70℃,萃取三次,过滤,合并滤液,得到提取液。
(2)将提取液离心过滤,再经过超滤、纳滤,温度控制在40~60℃,压力控制在0.6~2.2MPa;
(3)将提取溶液在真空条件下进行浓缩,浓缩的压力控制在0.01~0.03MPa,温度控制在60~70℃,得浓缩液,比重在1.1~1.2。
(4)制粒:将混合浓缩液中添加相应比例的麦芽糊精进行混合,混合后的原料放入70-85℃烘干箱内烘干,烘干后水份小于5%,粉碎、过40-60目筛,即得保健茶固体粉。
(5)水溶性***二酚的制备:用5-7倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用5-7倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,均质结束后,减压浓缩,回收乙醇,真空干燥,即得水溶性***二酚。
(6)调配:将水溶性***二酚、保健茶固体粉按比例进行混合。
(7)灌装:将调配好的原料放入全自动灌装机内进行灌装、封口;
(8)封口后的茶进入包装、打码等工序,即得所述含水溶性***二酚的保健茶。
本发明的优点:
本发明的优点在于把不溶于水的***二酚在未改变分子结构的前提下,通过包合法将高纯度的CBD包埋起来,极大的提高了CBD的水溶性、稳定性及生物利用度,充分发挥其功效,拓宽了CBD的应用领域。且原料的提取能够充分的将原料成分溶出,更好的发挥其功效。本产品风味独特,保健功效明显,具有清热解毒、抗炎、抗氧化、调节免疫等功效,是一款集美容、养生、休闲于一体的保健茶。
具体实施方式:
实施例1:一种含水溶性***二酚保健茶的制备方法,以重量份计,包括以下组分:
一种含水溶性***二酚保健茶的制备方法,包括以下步骤:
(1)原料准备:按配比准确称取金银花、菊花、蒲公英根、薄荷、胖大海、红景天,清水洗净,粉碎,放入提取罐中进行超声波逆流提取,料液比为1∶12,正向进料、反向进水,物料与水的流动为逆向连续动态流动。功率在600W,萃取时间60min,萃取温度为60℃,萃取三次,过滤,合并滤液,得到提取液。
(2)将提取液离心过滤,再经过超滤、纳滤,温度控制在60℃,压力控制在2.2MPa;
(3)将提取溶液在真空条件下进行浓缩,浓缩的压力控制在0.03MPa,温度控制在70℃,得浓缩液,比重在1.1~1.2。
(4)制粒:将混合浓缩液中添加相应比例的麦芽糊精进行混合,混合后的原料放入85℃烘干箱内烘干,烘干后水份小于5%,粉碎、过60目筛,即得保健茶固体粉。
(5)水溶性***二酚的制备:用5倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用7倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,均质结束后,减压浓缩,回收乙醇,真空干燥,即得水溶性***二酚。
(6)调配:将水溶性***二酚、保健茶固体粉按比例进行混合。
(7)灌装:将调配好的原料放入全自动灌装机内进行灌装、封口;
(8)封口后的茶进入包装、打码等工序,即得所述含水溶性***二酚的保健茶。
实施案例2:一种含水溶性***二酚保健茶的制备方法,以重量份计,包括以下组分:
一种含水溶性***二酚保健茶的制备方法,包括以下步骤:
(1)原料准备:将所用原料用清水洗净,粉碎,放入提取罐中进行超声波逆流提取,料液比为1∶12,正向进料、反向进水,物料与水的流动为逆向连续动态流动。功率在500W,萃取时间80min,萃取温度为60℃,萃取三次,过滤,合并滤液,得到提取液。
(2)将提取液离心过滤,再经过超滤、纳滤,温度控制在50℃,压力控制在2.0MPa;
(3)将提取溶液在真空条件下进行浓缩,浓缩的压力控制在0.01MPa,温度控制在60℃,得浓缩液,比重在1.1~1.2。
(4)制粒:将混合浓缩液中添加相应比例的麦芽糊精进行混合,混合后的原料放入70℃烘干箱内烘干,烘干后水份小于5%,粉碎、过40目筛,即得保健茶固体粉。
(5)水溶性***二酚的制备:用7倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用5倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,均质结束后,减压浓缩,回收乙醇,真空干燥,即得水溶性***二酚。
(6)调配:将水溶性***二酚、保健茶固体粉按比例进行混合。
(7)灌装:将调配好的原料放入全自动灌装机内进行灌装、封口;
(8)封口后的茶进入包装、打码等工序,即得所述含水溶性***二酚的保健茶。
实施案例3:一种含水溶性***二酚保健茶的制备方法,其特征在于,以重量份计,包括以下组分:
本发明提供了一种含水溶性***二酚保健茶的制备方法,包括以下步骤:
(1)原料准备:将所用原料用清水洗净,粉碎,放入提取罐中进行超声波逆流提取,料液比为1∶12,正向进料、反向进水,物料与水的流动为逆向连续动态流动。功率在200W,萃取时间120min,萃取温度为70℃,萃取三次,过滤,合并滤液,得到提取液。
(2)将提取液离心过滤,再经过超滤、纳滤,温度控制在40℃,压力控制在0.6MPa;
(3)将提取溶液在真空条件下进行浓缩,浓缩的压力控制在0.01~0.03MPa,温度控制在60~70℃,得浓缩液,比重在1.1~1.2。
(4)制粒:将混合浓缩液中添加相应比例的麦芽糊精进行混合,混合后的原料放入80℃烘干箱内烘干,烘干后水份小于5%,粉碎、过60目筛,即得保健茶固体粉。
(5)水溶性***二酚的制备:用7倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用7倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,均质结束后,减压浓缩,回收乙醇,真空干燥,即得水溶性***二酚。
(6)调配:将水溶性***二酚、保健茶固体粉按比例进行混合。
(7)灌装:将调配好的原料放入全自动灌装机内进行灌装、封口;
(8)封口后的茶进入包装、打码等工序,即得所述含水溶性***二酚的保健茶。
Claims (7)
1.一种含水溶性***二酚保健茶的制备方法,其特征在于,以重量份计,包括以下组分:
包括以下步骤:
(1)原料准备:将所用原料用清水洗净,粉碎,放入提取罐中进行超声波逆流提取,料液比为1∶12,正向进料、反向进水,物料与水的流动为逆向连续动态流动。功率在200~600W,萃取时间60~120min,萃取温度为60~70℃,萃取三次,过滤,合并滤液,得到提取液。
(2)将提取液离心过滤,再经过超滤、纳滤,温度控制在40~60℃,压力控制在0.6~2.2MPa;
(3)将提取溶液在真空条件下进行浓缩,浓缩的压力控制在0.01~0.03MPa,温度控制在60~70℃,得浓缩液,比重在1.1~1.2。
(4)制粒:将混合浓缩液中添加相应比例的麦芽糊精进行混合,混合后的原料放入70-85℃烘干箱内烘干,烘干后水份小于5%,粉碎、过40-60目筛,即得保健茶固体粉。
(5)水溶性***二酚的制备:用5-7倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用5-7倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,均质结束后,减压浓缩,回收乙醇,真空干燥,即得水溶性***二酚。
(6)调配:将水溶性***二酚、保健茶固体粉按比例进行混合。
(7)灌装:将调配好的原料放入全自动灌装机内进行灌装、封口;
(8)封口后的茶进入包装、打码等工序,即得所述含水溶性***二酚的保健茶。
2.根据权利要求1所述的一种含水溶性***二酚保健茶的制备方法,在所述步骤(1)中,原料提取为超声波逆流提取,料液比为1∶12。
3.根据权利要求2所述一种含水溶性***二酚保健茶的制备方法,其特征是:在所属的步骤(1)中,超声波处理功率200~600W,时间60~120min。
4.根据权利要求3所述一种含水溶性***二酚保健茶的制备方法,其特征是:在所属的步骤(2)中,提取物离心过滤经超滤后,再过纳滤,温度控制在40~60℃,压力控制在0.6~2.2Mpa。
5.根据权利要求4所述的一种含水溶性***二酚保健茶的制备方法,其特征是:在所属的步骤(3)中,浓缩比重在1.1~1.2。
6.根据权利要求5所述的一种含水溶性***二酚保健茶的制备方法,其特征是:在所属的步骤(4)中,用麦芽糊精进行制粒,且制粒后的固体水份小于5%。
7.根据权利要求6所述的种含水溶性***二酚保健茶的制备方法,其特征是:在所属的步骤(5)中,水溶性***二酚的制备包括如下步骤:用5-7倍乙醇将高纯度CBD晶体溶解,形成溶液;再将麦芽糊精用5-7倍纯水加热溶解,待完全溶解后将CBD溶液加入其中,搅拌均匀,进行均质,减压浓缩,真空干燥,即得水溶性***二酚。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010623392.2A CN111670985A (zh) | 2020-06-25 | 2020-06-25 | 一种含水溶性***二酚保健茶的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010623392.2A CN111670985A (zh) | 2020-06-25 | 2020-06-25 | 一种含水溶性***二酚保健茶的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111670985A true CN111670985A (zh) | 2020-09-18 |
Family
ID=72437655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010623392.2A Pending CN111670985A (zh) | 2020-06-25 | 2020-06-25 | 一种含水溶性***二酚保健茶的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111670985A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022077219A1 (zh) * | 2020-10-13 | 2022-04-21 | 深圳市舜宝科技有限公司 | 一种组合物、制备方法及一种茶烟弹 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105876017A (zh) * | 2016-05-12 | 2016-08-24 | 广西科技大学鹿山学院 | 一种银杏保健茶 |
CN106387158A (zh) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | 一种保健茶及其制备方法 |
CN110604195A (zh) * | 2019-09-10 | 2019-12-24 | 普洱茶王茶业集团股份有限公司 | 一种普洱茶保健饮品及其制备方法 |
CN111084262A (zh) * | 2020-01-20 | 2020-05-01 | 云南绿新生物药业有限公司 | 一种含水溶性***二酚的保健凉茶及其制备方法 |
US20200155479A1 (en) * | 2018-11-06 | 2020-05-21 | Dawn Annette Hackney | Method for infusing whole coffee beans and Tea Leaves with cannabis (Hemp) ingredients |
-
2020
- 2020-06-25 CN CN202010623392.2A patent/CN111670985A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105876017A (zh) * | 2016-05-12 | 2016-08-24 | 广西科技大学鹿山学院 | 一种银杏保健茶 |
CN106387158A (zh) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | 一种保健茶及其制备方法 |
US20200155479A1 (en) * | 2018-11-06 | 2020-05-21 | Dawn Annette Hackney | Method for infusing whole coffee beans and Tea Leaves with cannabis (Hemp) ingredients |
CN110604195A (zh) * | 2019-09-10 | 2019-12-24 | 普洱茶王茶业集团股份有限公司 | 一种普洱茶保健饮品及其制备方法 |
CN111084262A (zh) * | 2020-01-20 | 2020-05-01 | 云南绿新生物药业有限公司 | 一种含水溶性***二酚的保健凉茶及其制备方法 |
Non-Patent Citations (1)
Title |
---|
张旭等: "汉麻有效成分提取、表征及功能性研究", 《黑龙江科学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022077219A1 (zh) * | 2020-10-13 | 2022-04-21 | 深圳市舜宝科技有限公司 | 一种组合物、制备方法及一种茶烟弹 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101785552B (zh) | 覆盆子籽提取物及提取工艺 | |
CN101829187B (zh) | 果味青钱柳咀嚼片的制备方法 | |
CN105767397A (zh) | 一种健脾和胃银杏茶 | |
CN107412721B (zh) | 一种降血糖苦瓜多肽复方胶囊及其制备方法 | |
CN106261447A (zh) | 一种护肝、缓解酒后不适的固体饮料及其制备方法 | |
CN106721742A (zh) | 一种多功效黑蒜精华饮品及其制备方法 | |
CN107811252A (zh) | 一种保健蜂蜜及其制备方法 | |
CN104926954A (zh) | 一种从肉苁蓉中分离制备多糖、低聚糖及甘露醇的方法 | |
CN103564589A (zh) | 一种葛根保健饮料的配方及其制备方法 | |
CN105754000A (zh) | 羊栖菜多糖提取工艺 | |
CN105145987B (zh) | 三叶悬钩子保健速溶茶及其制备方法 | |
CN111670985A (zh) | 一种含水溶性***二酚保健茶的制备方法 | |
CN115844937B (zh) | 一种解酒护脑功能的苦苣菜提取物的制备方法及应用 | |
CN101946939A (zh) | 一种桔梗青梅饮料的制作方法 | |
CN105994735A (zh) | 一种提神醒脑银杏茶 | |
CN104997018A (zh) | 一种红豆杉酵素保健品及其制备方法和应用 | |
CN102477105A (zh) | 以南瓜藤蔓为原料联合制取多糖和黄酮的方法 | |
CN101991606A (zh) | 一种固体水溶性脱铅蜂胶的制备方法 | |
CN104920723A (zh) | 一种配合治疗消渴症的茶饮料及其制作方法 | |
CN112168944A (zh) | 预防新冠肺炎的中药组合物、提取物、其制备方法及应用 | |
KR101381277B1 (ko) | 홍삼을 함유하는 고장초 겔 | |
CN106343104A (zh) | 一种瓜蒌石斛保健粉的制作方法 | |
CN107593978A (zh) | 一种药制普洱熟茶以及药制普洱熟茶的制作方法 | |
CN106822629A (zh) | 茯苓玉米须口服液 | |
CN107518404A (zh) | 一种新鲜石斛保健胶粒及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200918 |
|
WD01 | Invention patent application deemed withdrawn after publication |